{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:10Z","timestamp":1792705750624,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1680"],"award-info":[{"award-number":["2023NSFSC1680"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273877"],"award-info":[{"award-number":["82273877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113919","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:42:41Z","timestamp":1748774561000},"page":"113919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Monocyte membrane-coated drug nanocrystals for enhanced targeted therapy of rheumatoid arthritis"],"prefix":"10.1016","volume":"384","author":[{"given":"Rongying","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2025.113919_bb0005","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.24178","article-title":"A population-based approach to reporting system-level performance measures for rheumatoid arthritis care","volume":"73","author":"Barber","year":"2021","journal-title":"Arthritis Care Res."},{"issue":"39","key":"10.1016\/j.jconrel.2025.113919_bb0010","article-title":"Cancer cell membrane camouflaged semi-Yolk@Spiky-shell nanomotor for enhanced cell adhesion and synergistic therapy","volume":"16","author":"Zhou","year":"2020","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.102020","article-title":"Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up","volume":"39","author":"Misra","year":"2025","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"6937","key":"10.1016\/j.jconrel.2025.113919_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113919_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"35","key":"10.1016\/j.jconrel.2025.113919_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20350","volume":"20","author":"Stevenson","year":"2016","journal-title":"Health technology assessment (Winchester, England)"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113919_bb0040","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","article-title":"A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40259-018-0320-3","article-title":"Targeting IL-6 or IL-6 receptor in rheumatoid arthritis: what\u2019s the difference?","volume":"32","author":"Avci","year":"2018","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113919_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s41927-023-00353-8","article-title":"Inflammasomes in rheumatoid arthritis: a pilot study","volume":"7","author":"Jiang","year":"2023","journal-title":"BMC rheumatology"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0065","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s10753-020-01301-1","article-title":"Understanding the role of Inflammasomes in rheumatoid arthritis","volume":"43","author":"Makkar","year":"2020","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113919_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0075","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2025.113919_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2018.09.007","article-title":"NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis","volume":"197","author":"Zhao","year":"2018","journal-title":"Clinical immunology (Orlando Fla.)"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113919_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113919_bb0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: a promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113919_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.113919_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114394","article-title":"Cell-based drug delivery systems and their in vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113919_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"26","key":"10.1016\/j.jconrel.2025.113919_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201701093","article-title":"Ly6Chi monocytes delivering pH-sensitive micelle loading paclitaxel improve targeting therapy of metastatic breast Cancer","volume":"27","author":"Lang","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113919_bb0120","doi-asserted-by":"crossref","unstructured":"J. Hou, X. Yang, S. Li, Z. Cheng, Y. Wang, J. Zhao, C. Zhang, Y. Li, M. Luo, H. Ren, J. Liang, J. Wang, J. Wang, J. Qin, Accessing neuroinflammation sites: Monocyte\/neutrophil-mediated drug delivery for cerebral ischemia, Science advances 5(7) (2019) eaau8301,doi:https:\/\/doi.org\/10.1126\/sciadv.aau8301.","DOI":"10.1126\/sciadv.aau8301"},{"key":"10.1016\/j.jconrel.2025.113919_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.11.027","article-title":"Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation","volume":"199","author":"Anselmo","year":"2015","journal-title":"Journal of controlled release"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113919_bb0130","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","article-title":"Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy","volume":"17","author":"He","year":"2017","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113919_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113919_bb0140","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113919_bb0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/1061186X.2020.1757102","article-title":"Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications","volume":"28","author":"Fan","year":"2020","journal-title":"J. Drug Target."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113919_bb0150","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1039\/D0BM02221G","article-title":"Strategies for the design of nanoparticles: starting with long-circulating nanoparticles, from lab to clinic","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113919_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121529","article-title":"Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes","volume":"284","author":"Li","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113919_bb0165","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1021\/acsnano.8b05200","article-title":"Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic Nanoreactor for starvation-activated Colon Cancer therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.113919_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2017.12.005","article-title":"Drug nanocrystals - versatile option for formulation of poorly soluble materials","volume":"537","author":"Peltonen","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113919_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.02.045","article-title":"Drug nanocrystals: fabrication methods and promising therapeutic applications","volume":"562","author":"Mohammad","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113919_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2019.06.006","article-title":"Hybrid drug nanocrystals","volume":"143","author":"Lu","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.jconrel.2025.113919_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Advanced materials (Deerfield Beach Fla.)"},{"issue":"23","key":"10.1016\/j.jconrel.2025.113919_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Advanced materials (Deerfield Beach, Fla.)"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0195","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/mp5001247","article-title":"Targeting of injectable drug nanocrystals","volume":"11","author":"Fuhrmann","year":"2014","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113919_bb0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","article-title":"Drug nanocrystals: in vivo performances","volume":"160","author":"Gao","year":"2012","journal-title":"Journal of controlled release"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113919_bb0205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.1960.03030070009002","article-title":"Treatment of rheumatoid arthritis with dexamethasone: two hundred fifty-one patients treated for short and long periods","volume":"174","author":"Cohen","year":"1960","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113919_bb0210","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acsbiomaterials.2c00026","article-title":"Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems","volume":"8","author":"Madamsetty","year":"2022","journal-title":"ACS Biomater Sci. Eng."},{"issue":"40","key":"10.1016\/j.jconrel.2025.113919_bb0215","doi-asserted-by":"crossref","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.113919_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931690","article-title":"Role of NLRP3 Inflammasome in rheumatoid arthritis","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113919_bb0230","doi-asserted-by":"crossref","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113919_bb0240","article-title":"Wright-Giemsa and nonspecific esterase staining of cells","volume":"3","author":"Strober","year":"2001","journal-title":"Curr Protoc Cytom Appendix"},{"issue":"27","key":"10.1016\/j.jconrel.2025.113919_bb0245","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113919_bb0250","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided Cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113919_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113919_bb0260","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1021\/acs.chemrev.7b00194","article-title":"Form follows function: nanoparticle shape and its implications for nanomedicine","volume":"117","author":"Kinnear","year":"2017","journal-title":"Chem. Rev."},{"issue":"27","key":"10.1016\/j.jconrel.2025.113919_bb0265","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1039\/D3TB00322A","article-title":"A computational study of the influence of nanoparticle shape on clathrin-mediated endocytosis","volume":"11","author":"Li","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113919_bb0270","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/acsami.5b10885","article-title":"How leucocyte cell membrane modified Janus microcapsules are phagocytosed by Cancer cells","volume":"8","author":"He","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113919_bb0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08923973.2018.1434793","article-title":"Experimental animal models for rheumatoid arthritis","volume":"40","author":"Choudhary","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113919_bb0280","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1021\/mp200328t","article-title":"The bone, the joints and the balm of Gilead","volume":"8","author":"Wang","year":"2011","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0285","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond.)"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113919_bb0290","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/nnm.11.79","article-title":"In vivo biodistribution of nanoparticles","volume":"6","author":"Almeida","year":"2011","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2025.113919_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114846","article-title":"Metabolomics combined with network pharmacology to study the mechanism of Shentong Zhuyu decoction in the treatment of rheumatoid arthritis","volume":"285","author":"Jiang","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113919_bb0300","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2008.099408","article-title":"Periarticular bone changes in rheumatoid arthritis: pathophysiological implications and clinical utility","volume":"68","author":"Goldring","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2025.113919_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867368","article-title":"Pathological osteoclasts and precursor macrophages in inflammatory arthritis","volume":"13","author":"Hasegawa","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113919_bb0310","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113919_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113919_bb0320","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and Interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis & rheumatology (Hoboken, N.J.)"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:49:36Z","timestamp":1779511776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":64,"alternative-id":["S0168365925005395"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113919","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocyte membrane-coated drug nanocrystals for enhanced targeted therapy of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113919"}}